{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:36:32Z","timestamp":1787502992481,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.coi.2026.102756","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T03:14:59Z","timestamp":1773458099000},"page":"102756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Malaria immunity in the infant: progress and pitfalls"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2515-2989","authenticated-orcid":false,"given":"Margaret E","family":"Feeney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2026.102756_bib1","unstructured":"World Health Organization: World Malaria Report, 2025; 2025. Available from:\u3008https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2025\u3009."},{"key":"10.1016\/j.coi.2026.102756_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000221","article-title":"Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study","volume":"7","author":"Dellicour","year":"2010","journal-title":"PLoS Med"},{"key":"10.1016\/j.coi.2026.102756_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat6176","article-title":"In utero priming of highly functional effector T cell responses to human malaria","volume":"10","author":"Odorizzi","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2026.102756_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000116","article-title":"Can prenatal malaria exposure produce an immune tolerant phenotype?: a prospective birth cohort study in Kenya","volume":"6","author":"Malhotra","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.coi.2026.102756_bib5","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/imr.12806","article-title":"The immune response to malaria in utero","volume":"293","author":"Feeney","year":"2020","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coi.2026.102756_bib6","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.cell.2019.05.046","article-title":"Fc characteristics mediate selective placental transfer of IgG in HIV-infected women","volume":"178","author":"Martinez","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.coi.2026.102756_bib7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cell.2019.05.044","article-title":"Fc glycan-mediated regulation of placental antibody transfer","volume":"178","author":"Jennewein","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.coi.2026.102756_bib8","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3389\/fimmu.2017.01294","article-title":"Factors affecting the FcRn-mediated transplacental transfer of antibodies and implications for vaccination in pregnancy","volume":"8","author":"Wilcox","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2026.102756_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1017\/S0031182015001626","article-title":"Plasmodium malaria and antimalarial antibodies in the first year of life","volume":"143","author":"Dobbs","year":"2016","journal-title":"Parasitology"},{"key":"10.1016\/j.coi.2026.102756_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00439","article-title":"Differential patterns of IgG subclass responses to Plasmodium falciparum antigens in relation to malaria protection and RTS,S vaccination","volume":"10","author":"Doba\u00f1o","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2026.102756_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002403","article-title":"Associations between an IgG3 polymorphism in the binding domain for FcRn, transplacental transfer of malaria-specific IgG3, and protection against Plasmodium falciparum malaria during infancy: a birth cohort study in Benin","volume":"14","author":"Dechavanne","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.coi.2026.102756_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau1458","article-title":"Challenges and strategies for developing efficacious and long-lasting malaria vaccines","volume":"11","author":"Beeson","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2026.102756_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1084\/jem.20021072","article-title":"Malaria blood stage suppression of liver stage immunity by dendritic cells","volume":"197","author":"Oca\u00f1a-Morgner","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2026.102756_bib14","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1084\/jem.20121972","article-title":"Apoptosis and dysfunction of blood dendritic cells in patients with falciparum and vivax malaria","volume":"210","author":"Pinzon-Charry","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2026.102756_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003864","article-title":"IFN\u03b3\/IL-10 co-producing cells dominate the CD4 response to malaria in highly exposed children","volume":"10","author":"Jagannathan","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2026.102756_bib16","doi-asserted-by":"crossref","first-page":"627","DOI":"10.4269\/ajtmh.23-0696","article-title":"Previous malaria exposures and immune dysregulation: developing strategies to improve malaria vaccine efficacy in young children","volume":"110","author":"Dobbs","year":"2024","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.coi.2026.102756_bib17","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.51889","article-title":"A delayed fractionated dose RTS,S AS01 vaccine regimen mediates protection via improved T follicular helper and B cell responses","volume":"9","author":"Pallikkuth","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.coi.2026.102756_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial","volume":"386","author":"RTS,S Clinical Trials Partnership","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2026.102756_bib19","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S1473-3099(15)00239-X","article-title":"Immunogenicity of the RTS,S\/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial","volume":"15","author":"White","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"24","key":"10.1016\/j.coi.2026.102756_bib20","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1056\/NEJMoa1208394","article-title":"A phase 3 trial of RTS,S\/AS01 malaria vaccine in African infants","volume":"367","author":"RTS,S Clinical Trials Partnership","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2026.102756_bib21","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJMoa1102287","article-title":"First results of phase 3 trial of RTS,S\/AS01 malaria vaccine in African children","volume":"365","author":"The RTS SCTP","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2026.102756_bib22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ni0311-189","article-title":"Challenges in infant immunity: implications for responses to infection and vaccines","volume":"12","author":"PrabhuDas","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2026.102756_bib23","article-title":"Efficacy and safety of the RTS,S\/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites","volume":"11","author":"RTS,S Clinical Trials Partnership","year":"2014","journal-title":"PLOS Med"},{"key":"10.1016\/j.coi.2026.102756_sbref23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1473-3099(24)00527-9","article-title":"The effect of Plasmodium falciparum exposure and maternal anti-circumsporozoite protein antibodies on responses to RTS,S\/AS01E vaccination in infants and children: an ancillary observational immunological study to a phase 3, randomised clinical trial","volume":"25","author":"Maci\u00e0","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coi.2026.102756_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.634749","article-title":"Malaria and early life immunity: competence in context","volume":"12","author":"Callaway","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2026.102756_bib26","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jamapediatrics.2017.0638","article-title":"The influence of maternally derived antibody and infant age at vaccination on infant vaccine responses: an individual participant meta-analysis","volume":"171","author":"Voysey","year":"2017","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.coi.2026.102756_bib27","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/imcb.12415","article-title":"Epitope masking may limit antibody boosting to malaria vaccines","volume":"99","author":"Kurtovic","year":"2021","journal-title":"Immunol & Cell Biol"},{"key":"10.1016\/j.coi.2026.102756_bib28","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/6560","article-title":"Immunity to non-cerebral severe malaria is acquired after one or two infections","volume":"5","author":"Gupta","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2026.102756_bib29","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.chom.2019.10.012","article-title":"Protective immunity against severe malaria in children is associated with a limited repertoire of antibodies to conserved PfEMP1 variants","volume":"26","author":"Tessema","year":"2019","journal-title":"Cell Host & Microbe"},{"key":"10.1016\/j.coi.2026.102756_bib30","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1128\/IAI.00593-10","article-title":"Hierarchical, domain type-specific acquisition of antibodies to Plasmodium falciparum erythrocyte membrane protein 1 in Tanzanian children","volume":"78","author":"Cham","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.coi.2026.102756_sbref30","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41586-024-08220-3","article-title":"Broadly inhibitory antibodies to severe malaria virulence proteins","volume":"636","author":"Reyes","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.coi.2026.102756_bib32","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb4757","article-title":"Mapping functional humoral correlates of protection against malaria challenge following RTS,S\/AS01 vaccination","volume":"12","author":"Suscovich","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2026.102756_bib33","doi-asserted-by":"crossref","first-page":"26733","DOI":"10.1074\/jbc.M202069200","article-title":"Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fc\u03b3RIII and antibody-dependent cellular toxicity","volume":"277","author":"Shields","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2026.102756_sbref33","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-55543-w","article-title":"Acquisition of Fc-afucosylation of PfEMP1-specific IgG is age-dependent and associated with clinical protection against malaria","volume":"16","author":"Lopez-Perez","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2026.102756_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-31880-6","article-title":"Age-dependent changes in circulating Tfh cells influence development of functional malaria antibodies in children","volume":"13","author":"Chan","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2026.102756_bib36","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1056\/NEJMoa2313892","article-title":"Safety and efficacy of immunization with a late-liver-stage attenuated malaria parasite","volume":"391","author":"Lamers","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2026.102756_bib37","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41591-024-03347-2","article-title":"Single immunization with genetically attenuated Pf\u2206mei2 (GA2) parasites by mosquito bite in controlled human malaria infection: a placebo-controlled randomized trial","volume":"31","author":"Roozen","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2026.102756_sbref37","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-021-01470-y","article-title":"Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial","volume":"27","author":"Oneko","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2026.102756_bib39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1473-3099(21)00332-7","article-title":"Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial","volume":"22","author":"Sissoko","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coi.2026.102756_sbref39","article-title":"Innate immune activation restricts priming and protective efficacy of the radiation-attenuated PfSPZ malaria vaccine [Internet]","volume":"9","author":"Senkpeil","year":"2024","journal-title":"Am Soc Clin Investig"},{"key":"10.1016\/j.coi.2026.102756_bib41","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1038\/s41590-024-01938-2","article-title":"Monoclonal antibodies to the circumsporozoite proteins as an emerging tool for malaria prevention","volume":"25","author":"Wang","year":"2024","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2026.102756_bib42","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.143958","article-title":"Enhancing durability of CIS43 monoclonal antibody by Fc mutation or AAV delivery for malaria prevention","volume":"6","author":"Kisalu","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.coi.2026.102756_sbref42","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1056\/NEJMoa2312775","article-title":"Subcutaneous administration of a monoclonal antibody to prevent malaria","volume":"390","author":"Kayentao","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2026.102756_bib44","doi-asserted-by":"crossref","first-page":"704","DOI":"10.4269\/ajtmh.23-0186","article-title":"Post-discharge risk of mortality in children under 5 years of age in Western Kenya: a retrospective cohort study","volume":"109","author":"Kwambai","year":"2023","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.coi.2026.102756_bib45","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/S2214-109X(23)00492-8","article-title":"Post-discharge malaria chemoprevention in children admitted with severe anaemia in malaria-endemic settings in Africa: a systematic review and individual patient data meta-analysis of randomised controlled trials","volume":"12","author":"Phiri","year":"2024","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.coi.2026.102756_bib46","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2024-016600","article-title":"Inpatient and postdischarge mortality among children with anaemia and malaria parasitaemia in Kenya: a cohort study","volume":"9","author":"Ngari","year":"2024","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.coi.2026.102756_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms2605","article-title":"A model of parity-dependent immunity to placental malaria","volume":"4","author":"Walker","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2026.102756_bib48","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/infdis\/jiy168","article-title":"Etiology of placental Plasmodium falciparum malaria in African women","volume":"218","author":"Ofori","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2026.102756_bib49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pt.2024.11.003","article-title":"Placental malaria and circumsporozoite protein-specific immunity","volume":"41","author":"Hviid","year":"2025","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.coi.2026.102756_bib50","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1093\/cid\/ciy380","article-title":"Persistent Plasmodium falciparum infection in women with an intent to become pregnant as a risk factor for pregnancy-associated malaria","volume":"67","author":"Tuikue Ndam","year":"2018","journal-title":"Clin Infect Dis"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791526000336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791526000336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T04:23:50Z","timestamp":1779510230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791526000336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":50,"alternative-id":["S0952791526000336"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2026.102756","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Malaria immunity in the infant: progress and pitfalls","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2026.102756","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102756"}}